Poland Pharmaceuticals & Healthcare Report Q1 2014 - New Market Research Report
The threat of price cuts in 2014 presents downside risks to the Polish pharmaceutical market, especially if the government does not compromise with the industry. Nevertheless, over a long term horizon, we see growth opportunities in the Polish pharmaceutical market.
View full press release